Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension
Clinical trial NCT06212648 · COMPLETED
Trial details
- NCT number
- NCT06212648
- Sponsor
- Shin Poong Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2022-11-27
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.